InsidersTradesSigma
Explore the complete record of transactions filed by Walsh Angela, Vice-Président Senior des Finances. Officer active across 1 companies, notably Virios Therapeutics, Inc.. Cumulatively, 1 disclosures have been logged. Total volume traded: €9k. The latest transaction was filed on 23 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Angela Walsh serves as the SVP of Finance at Virios Therapeutics, Inc. She is responsible for financial management and the financial strategy of the company. Her role includes overseeing financial operations and ensuring compliance with regulations. Angela Walsh plays a key role in supporting the strategic objectives of Virios Therapeutics, Inc.